Small-batch manufacturing in the biotech industry presents unique challenges that require innovative solutions. Dr. Jitendra Amrutkar emphasizes the importance of isolators and restricted access barrier systems for contamination control and cost-efficiency in aseptic environments. To ensure precision filling for low-volume biologics, micro fillers are recommended to minimize product loss and ensure dososity accuracy. Additionally, digital management of manufacturing and batch records through manufacturing execution systems and electronic batch records improves traceability, compliance, and data integrity, crucial for personalized medicine. ACG’s capsule filling and inspection systems are highlighted for their high precision and suitability for clinical and personalized applications. Modular process design, single-use technologies, and flexible filling lines are also key strategies for overcoming challenges in small-batch manufacturing. The rise of personalized therapies in the pharmaceutical industry has increased the demand for specialized manufacturing processes, leading to a focus on small batch sizes. The automation of patient and manufacturing data is seen as essential for future production models, but the industry’s readiness to adopt such automation remains a question. With the complexity of small-batch manufacturing for personalized medicine, factors like processing speed, flexibility, and product yield become critical considerations. Every drop of high-value drugs is significant, emphasizing the need to minimize product loss. Hanns-Christian Mahler underscores the importance of maximizing yield to control the cost-of-goods for biologics, particularly in the context of smaller batch sizes. Ready-to-use containers are recommended for small-batch manufacturing to streamline processes and reduce the need for extensive washing and sterilization equipment. Overall, the design of manufacturing facilities and processes must align with the requirements of small-batch production to optimize efficiency and cost-effectiveness.
Read more from pharmtech.com
